Prevalence of Diabetes in Patients Who Are Candidates for Spine Surgery
ConditionSpine Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
About this trial
The purpose of the study is to assess, through systematic screening, the prevalence of diabetes or prediabetes in patients who are candidates for lumbar spine surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients,
Patients who have been informed of the research and have not indicated their opposition to the use of their medical data,
Patients who are candidates for their first lumbar spine surgery, whether instrumented or not
Disqualifiers
Non-instrumented percutaneous surgery (cementoplasty)
Presence of spinal osteosynthesis equipment
Surgery performed for an infectious or tumoral spinal condition
Surgery via an anterior or lateral approach
Trial population
Population of patients who are candidates for lumbar spine surgery
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Diabetes or prediabetes présence
Diabetes is defined as a blood glucose level of at least 1.26 g/L and a glycated hemoglobin level greater than or equal to 6.5%. Prediabetes is defined as a blood glucose level greater than 1.10 g/L and less than 1.26 g/L and a glycated hemoglobin level between 5.7% and 6.4%.
Time frame
Day 1Secondary outcomes
1
Low back pain
Pain will be assessed by the patient on a visual analog scale from 0 to 10 (0 = no pain, 10 = maximum pain).
Time frame
Day 02
Low back pain
Pain will be assessed by the patient on a visual analog scale from 0 to 10 (0 = no pain, 10 = maximum pain).
Time frame
Month 33
Radicular pain
Pain will be assessed by the patient on a visual analog scale from 0 to 10 (0 = no pain, 10 = maximum pain).
Time frame
Day 04
Radicular pain
Pain will be assessed by the patient on a visual analog scale from 0 to 10 (0 = no pain, 10 = maximum pain).
Time frame
Month 3Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov